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ABSTRACT
Background: Subjective cognitive failures (SCF) and subjective memory failures (SMF) have been
reported to be an early predictor of Alzheimer disease (AD) and have been attributed to white
matter lesions (WML). Since AD is characterized by hippocampal degeneration, it is surprising
that its relation with hippocampal atrophy has been investigated only sparsely. Previous studies
on this are rare, limited in sample size, and did not adjust for WML.
Objective: To determine the relation between SCF and hippocampal volume in strata of objective
cognitive performance among elderly without dementia with incidental WML.
Methods: The Radboud University Nijmegen Diffusion tensor and MRI Cohort study is a prospec-
tive cohort study among 503 subjects with WML aged between 50 and 85 years. All subjects
underwent FLAIR and T1 MRI scanning. The amount of SCF and SMF was rated by the Cognitive
Failure Questionnaire. Cognitive function was assessed by a cognitive screening battery. Volu-
metric measures of hippocampus and WML were manually performed. We assessed the relation
between hippocampal volume and SCF and SMF adjusted for age, sex, education, depression,
intracranial volume, and WML volume.
Results: Subjects with SCF and SMF had lower hippocampal volumes than those without (p 
0.01 and p  0.02). This was most noteworthy in subjects with good objective cognitive perfor-
mance (ptrend  0.007 and ptrend  0.03), and not in those with poor objective cognitive perfor-
mance.
Conclusion: Subjective cognitive failures (SCF) are associated with lower hippocampal volume,
even in subjects without objective cognitive impairment and independent of white matter lesions.
SCF has a radiologic detectable pathologic-anatomic substrate. Neurology® 2008;71:1152–
1159
GLOSSARY
AD  Alzheimer disease; ANCOVA  analysis of covariance; CES-D  Center of Epidemiologic Studies–Depression Scale;
FLAIR  fluid attenuated inversion recovery; GM  gray matter; ICV  intracranial volume; MMSE  Mini-Mental State
Examination; RUN DMC  Radboud University Nijmegen Diffusion tensor and MRI Cohort; SCF  subjective cognitive fail-
ures; SEF  subjective executive failures; SMF  subjective memory failures; TE  echo time; TI  inversion time; TR 
repetition time; WMwhite matter; WMLwhite matter lesions.
Clinicians are often confronted with elderly patients who report subjective cognitive com-
plaints including memory complaints such as forgetting appointments in the near future or
recent occurrences. Despite considerable controversy,1,2 several studies have found a relation
between these subjective cognitive complaints and objective cognitive impairment, such as loss
of executive and memory function as assessed by neuropsychology in elderly without demen-
tia.3,4 More noteworthy, subjective complaints in individuals with normal cognition as assessed
by formal neuropsychological testing predict Alzheimer disease (AD) years after initial subjec-
tive complaints.5 Hence, these subjective complaints, distinguished in memory complaints and
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executive complaints, could be the earliest
sign of cognitive dysfunction and might be a
sensitive tool to identify those at risk for AD.
Early in its course, AD is characterized by
a slowly progressive memory deficit due
to gradual hippocampal degeneration, ulti-
mately resulting in hippocampal atrophy.6
The memory deficit is often accompanied by
loss of executive function, presumably caused
by frontal gray matter atrophy, but also by
white matter lesions (WML).7,8 Neuropatho-
logic studies indicate that hippocampal atro-
phy and WML may be present years or even
decades before cognitive symptoms become
detectable.9-11
Depressive symptoms are also often present
during early AD. There is an ongoing debate
whether these symptoms influence or even
cause cognitive complaints or whether a pre-
stage of Alzheimer pathology is responsible
for the cognitive complaints, despite spared
cognition during formal testing.1,2,4,12 How-
ever, the presence of depressive symptoms is
usually not taken into account in studies that
assessed the relation between cognitive com-
plaints, objective cognitive function, and their
underlying pathologic substrate.
We hypothesized that subjective memory
complaints and subjective executive com-
plaints are already neuroradiologically charac-
terized by hippocampal atrophy and WML,
even in subjects without any objective cogni-
tive impairment. Only a few studies have ad-
dressed this issue. Two large population-based
studies found that WML were related to cog-
nitive complaints, but did not adjust for hip-
pocampal volume.4,12 Besides that, WML
were rated semiquantitatively or by auto-
mated segmentation, potentially leading to
underestimation of the actual WML bur-
den.13 Conversely, other studies related hip-
pocampal volume to subjective memory
complaints, without taking the degree of
WML into account.12,14,15 In addition, most
studies did not adjust for depressive symp-
toms, being a potential confounder.
We therefore wanted to investigate whether
subjective cognitive complaints on both the
memory and executive domain were associated
with hippocampal andWML volume in 503 in-
dependent living healthy elderly with incidental
WML.
METHODS Study population. This study is embedded
within the Radboud University Nijmegen Diffusion tensor and
MRI Cohort (RUN DMC) study. The RUN DMC study pro-
spectively investigates causes and cognitive and motor conse-
quences of longitudinal functional and structural changes in the
brain of individuals with incidental WML. Baseline investiga-
tions took place in 2006. Consecutive subjects, aged between 50
and 85 years, who visited the neurology outpatient clinic be-
tween October 2002 and November 2006 and who underwent
routine diagnostic brain imaging, for reasons not related to the
cognitive and motor study outcome (including collapses, mild
traumatic brain injury, vertigo, chronic head pain, or cranial
nerve palsy), were eligible for participation. Exclusion criteria
were any abnormality on the routine diagnostic brain imaging
that could interfere with the outcome (space occupying lesions,
hemorrhages, large-artery infarcts), MRI contraindications, and
prevalent dementia. Subjects were selected in strata of age (5
years), sex, and WML severity according to the ARWMC scale.16
Upon agreement to participate in the study they underwent an
extensive MRI protocol as part of the study on which all MRI
measures reported here were based (see below).
In 2006, 1,004 subjects were selected for possible participa-
tion. On the basis of MRI contraindications and the other exclu-
sion criteria 299 subjects were excluded. The final sample
consisted of 705 subjects of whom 503 agreed to participate
(response 71.3%). Each participant signed an informed consent.
The Medical Review Ethics Committee region Arnhem-
Nijmegen approved the study.
MRI acquisition. All subjects underwent a 1.5 Tesla MRI
scanning on the same Magnetom Sonata scanner (Siemens, Er-
langen, Germany). The scanning protocol included whole brain
T1 three-dimensional MPRAGE imaging (repetition time [TR]/
echo time [TE]/inversion time [TI] 2,250/3.68/850 msec; flip
angle 15°; voxel size 1.0  1.0  1.0 mm) and fluid attenuated
inversion recovery (FLAIR) image (TR/TE/TI 9,000/84/2,200
msec; voxel size 1.0  1.2  6.0 mm [including gap of 1 mm];
number of excitations 2).
Hippocampus and intracranial volume. One experienced
investigator blinded to clinical data, total WML volume, and
FLAIR images (I.W.M.v.U.) manually segmented left and right
hippocampus on the MPRAGE image using the interactive soft-
ware program ITK-SNAP.17 Anatomic boundaries were coro-
nally determined with neuroanatomic atlases18,19 and actual
segmentation was performed using a previously published proto-
col.20 In short, segmentation was performed from posterior to
anterior. The posterior border of the hippocampus was identi-
fied in the slice before the level in which the crurae fornices
appeared in full view. The anterior border of the hippocampus
was defined as the slice in which the hippocampus was no longer
present, and the amygdala fully covered the hippocampus.20-22
The superior border was the inferior horn of the lateral ventricle;
the inferior border was determined by the white matter. The
lateral border was defined by the temporal horn of the lateral
ventricle and the white matter adjacent to the hippocampus.
Volumes were calculated for the left and right hippocampus
separately by summing all voxel volumes of the segmented areas.
Intrarater studies on a random sample of 50 MRI scans showed
an intraclass correlation coefficient for the left hippocampus of
0.73, and for the right hippocampus of 0.79.
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For the same image, gray (GM) and white matter (WM)
tissue and CSF probability maps were computed using SPM5
routines (Wellcome Department of Cognitive Neurology, Uni-
versity College London, UK). Total GM, WM, and CSF vol-
umes were calculated by summing all voxel volumes that had a p
 0.5 for belonging to the tissue class. Intracranial volume
(ICV) was taken as the sum of total GM, WM, and CSF.12
WML volume.WML were manually segmented on transversal
FLAIR images. WML were defined as hyperintense lesions on
FLAIR MRI and not CSF like hypointense lesions on T1-
weighted image. WML volume was calculated in the same fash-
ion as for the hippocampi. Gliosis surrounding lacunar and
territorial infarctions was not considered to be WML.16,23 Two
trained raters (I.W.M.v.U., L.J.B.v.O.) segmented all scans. For
the total WML volume the inter-rater intraclass correlation coef-
ficient was 0.98 in a random sample of 50 scans.
Subjective cognitive failures. Information on subjective
cognitive failures (SCF) was assessed by a 15-item semistruc-
tured interview based on the Cognitive Failure Questionnaire4,24
(table 1). Responses were added to a sumscore for SCF with a
maximum of 25. According to previous studies, subjective
failure in remembering, word finding, planning, concentration,
or slowness in thought had a higher weight in the sumscores
(score range of 0–3: none, mild, moderate, severe) than the 10
other items (0–1). SCF were considered present when a subject
reported at least one moderate problem (score 2 or higher) on an
item having a score range of 0–3 or a score of 1 on dichotomous
items.4 In addition, we assessed whether subjects reported pro-
gression of remembering, word finding, planning, concentra-
tion, or slowness of thought over the past 5 years (part of the
Subjective Cognitive Failures Questionnaire, table 1). Progres-
sion was defined as obvious progression of at least one failure or
little progression on more than one of these failures.4
SCF were subdivided into subjective memory failures (SMF)
and subjective executive failures (SEF). SMF were considered
present if failures were reported in 1 of the 10 items concerning
memory problems; SEF were considered present if failures in
planning, concentration, and slowness in thought were report-
ed.4
Objective cognitive performance. Cognitive performance
was assessed by a standardized neuropsychological test battery
that has been used in other large-scale epidemiologic studies of
cognition in healthy elderly.8,25,26 The tests were administered by
two trained investigators (A.G.W.v.N., K.F.d.L.) and included
the Mini-Mental State Examination (MMSE),27 a 15-word ver-
bal learning test,28 an abbreviated Stroop test consisting three
subtasks,29 the Paper and Pencil Memory Scanning Task,30 a ver-
bal fluency task in which as many animals and as many jobs as
possible had to be named within 60 seconds,31 and the Symbol-
Digit Substitution Task, which is a modified version of the Sym-
bol Digit Modalities Test.32
Performance across tests was made comparable by transform-
ing the raw test scores into Z-scores as described elsewhere.33
Z-scores of the tests that had higher scores representing worse
performance, like the speed score, were inverted (Z). From
these Z-scores we calculated compound scores for cognitive
function, memory function, and executive function, as described
previously.8 In short, compound score for cognitive function was
calculated as the mean of the Z-scores of the one-letter subtask of
the Paper-and-Pencil Memory Scanning Task, the reading sub-
task of the Stroop test, the Letter-Digit Substitution Task, the
added score of the three learning trials of 15-word verbal learn-
ing test, and the delayed recall of this test.8 A compound score
for memory function was calculated by taking the mean of two
Z-scores of the 15-word verbal learning test: one for the added
scores on the three learning trials, and one for the delayed recall.8
The compound score for executive function was calculated as
the mean of the Z-scores of the verbal fluency test, the Symbol-
Digit Substitution Task, and the interference subtask of the
Stroop test.
If the test assistant encountered problems, a code was given
for test status and the result was not used in the calculation of the
Z-scores. Separate codes were given for lack of motivation
(2.7%), presence of a physical handicap (1.2%), or deviation
from the instructions (2.9%). For 465 subjects (93%), reliable
compound scores could be calculated.
Other measurements. The following characteristics were
considered as possible confounders: age, sex, education (accord-
ing to Verhage),34 and depressive symptoms. Depressive symp-
toms were considered present when a subject had a score16 on
the Center of Epidemiologic Studies–Depression Scale (CES-
D)35,36 and/or the use of antidepressive medication.36 ICV was
also considered as a potential confounder.
Table 1 Subjective Cognitive Failures Questionnaire (n 500)
Question Score
range
% with
problems
Memory problems
Do you consider yourself as forgetful? 0–3 54.2
Have you experienced any progression on this item?* 0–2 56.0
Do you experience word-finding problems? 0–3 61.8
Have you experienced any progression on this item?* 0–2 26.7
Do you ever forget names of family members or friends? 0–1 59.2
Do people tell you that you tell stories twice? 0–1 39.2
Do you ever forget occurrences of the past 1 or 2 days? 0–1 32.2
Do you worry about forgetfulness? 0–1 42.2
Do you experience hindrance in everyday life because of
forgetfulness?
0–1 37.8
Do you ever misplace items at odd locations, leave the
stove burning, or forget how to use everyday appliances?
0–1 11.2
Do you ever forget appointments? 0–1 21.2
Do you ever lose your way in your neighborhood or do not
recognize a person with whom you are actually well
acquainted?
0–1 10.2
Related executive problems
Have you experienced problems with planning of
activities?
0–3 15.2
Have you experienced any progression on this item?* 0–2 41.7
Do you have concentration problems? 0–3 39.6
Have you experienced any progression on this item?* 0–2 48.1
Do you think or act more slowly than you used to? 0–3 47.4
Have you experienced any progression on this item?* 0–2 52.1
Remaining problems
Do you feel more exhausted than you used to? 0–1 30.2
Doyouever feel so depressed that you lose interest in life? 0–1 22.8
*Percentage of participants with subjective failure on the accompanying item who reported
little (score 1) or obvious (score 2) progression over the past 5 years on that particular item.
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Statistical analysis. Statistical analyses were performed with
the use of SPSS 14.0 for Windows. Demographic characteristics
were compared between subjects with or without SCF by sex-
and age-adjusted analysis of covariance (ANCOVA) (by so called
“forced entry”) (table 2).
Mean hippocampal and WML volume and the proportion
of subjects with severe WML (highest quintile)4 were calculated
for subjects with or without SCF, SMF, or SEF by ANCOVA
(table 3). All assumptions for ANCOVA were verified for each
analysis.
Next, we calculated the mean hippocampal and WML vol-
ume in subjects with and without SCF by severity of the failures
(ANCOVA). Subjects who reported no SCF, as defined earlier,
were considered having “no SCF.” The group with SCF was
dichotomized at the upper tertile of the SCF score, which re-
flected “severe SCF”; the lower two tertiles were defined as
“moderate SCF.” SMF and SEF were categorized accordingly.
To investigate whether the level of objective cognitive per-
formance modified the association between hippocampal or
WML volume and severity of SCF, we analyzed this relation
stratified by objective performance, according to tertiles of the
compound score for cognitive function (poor, moderate, or
good).4
Finally, we investigated whether progression of failures was
related to hippocampal or WML volume.
For the trend analysis of the ANCOVA results, groups of
severity of failures (none, moderate, severe) were considered as a
continuous variable in a multiple linear regression model. Age,
sex, education, depressive symptoms, ICV, and where appropri-
ate WML volume and hippocampal volume were put together
into the model (so called “forced entry”).
RESULTS Of the 503 subjects, one was excluded
because of an automatic segmentation problem and
two because of an incomplete SCF questionnaire.
The presence of depressive symptoms was assessed in
498 subjects. Demographic characteristics are shown
in table 2. Subjects reporting SCF were older (p 
0.001) and had more depressive symptoms (p 
0.003) adjusted for age and sex. Subjective failures
on all three domains (SCF, SMF, and SEF) were as-
sociated with reduced objective performance, inde-
pendent of depressive symptoms, WML, and
hippocampal volume (p  0.01).
Table 3 illustrates that subjects with SCF had a
lower hippocampal volume than those without (p 
0.01). Subsequent analysis showed that this was also
evident in subjects with SMF (p  0.01) and SEF
(p 0.07). Additional adjustment for WML volume
did not significantly change the effect. No relation
was found between SCF and WML volume (p 
0.1), except for subjects reporting SEF who more of-
ten had severe WML (25%) than those who did not
(15%; p  0.05).
Table 2 Characteristics of the 500 subjects who completed the SCFQuestionnaire with or without
subjective cognitive failures
Subjective cognitive failures
Characteristic Total (n 500) Yes (n 453) No (n 47) p*
Age, y 65.6 (8.8) 66.1 (8.7) 61.1 (8.7) 0.001
Male/female 281/219 251/202 30/17 0.244
Subjects with only primary education 47 (9.4%) 45 (9.9%) 2 (4.3%) 0.654
MMSE 28.2 (1.6) 28.1 (1.6) 28.4 (1.6) 0.249
CES-D 10.9 (9.4) 11.4 (9.3) 6.1 (9.4) 0.001
Subjects with depressive symptoms† 166 (33%) 160 (35%) 6 (13%) 0.003
Subjects with CES-D>16 139 (28%) 135 (30%) 4 (9%) 0.003
Subjects with antidepressive medication 62 (12%) 59 (13%) 3 (6%) 0.271
Subjective cognitive failures (SCF)
Sumscore on the SCF questionnaire 8.5 (5.7) 9.3 (5.2) 0.5 (5.2) 0.001
Subjects with SCF 453 (91%)
Sumscore of subquestionnaire on SMF 5.4 (3.5) 5.9 (3.1) 0.4 (3.1) 0.001
Subjects with SMF 442 (88%)
Sumscore of subquestionnaire on SEF 2.5 (2.3) 2.8 (2.3) 0.2 (2.2) 0.001
Subjects with SEF 304 (61%)
Subjects with SCF reporting its progression 194 (43%)
Values are mean (SD) or n (%).
*Analysis of covariance adjusted for age and sex, where appropriate.
†Defined as CES-D scores16 and/or the use of antidepressive medication (n 498).
MMSE  Mini-Mental State Examination; CES-D  Center of Epidemiologic Studies–Depression scale; SMF  subjective
memory failures; SEF subjective executive failures.
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There was also a relation of decreasing hippo-
campal volume by increasing severity (no, mod-
erate, and severe failures) of SCF (ptrend  0.024),
SMF (ptrend  0.01), and SEF (ptrend  0.07).
In figure 1, hippocampal volumes are given in
strata of actual cognitive performance for sub-
jects with severe, moderate, and no SCF. The dif-
ference in hippocampal volume across these differ-
ent groups with SCF was most apparent in subjects
with good cognitive performance (ptrend  0.005).
This relation was also found for SMF (ptrend 
0.024; figure 2), with borderline significance for
subjects with moderate memory performance
(ptrend  0.076). Additional adjustment for WML
did not change the magnitude of the associations.
These relations were not found for WML volume, in
neither of the objective cognitive strata nor in the
whole group analysis.
Progression of failures was not associated with
hippocampal volume, nor with WML volume.
DISCUSSION We found that SCF were associated
with lower hippocampal volume, independent of de-
pressive symptoms and WML volume, in elderly in-
dividuals with incidental WML. This relation was
most evident in subjects with intact cognition as re-
vealed by neuropsychological testing.
In our study the proportion of subjects report-
ing SCF (91%) and SMF (88%) was higher than
in other studies, which reported percentages be-
tween 26 and 72%.3,4,12 A possible explanation for
our relatively high frequency might be the method
used to determine SCF. SCF were not identified
through spontaneous reporting, but by actively
asking for it, potentially resulting in a higher de-
gree of reported failures. Another explanation could
be that all subjects were recruited through our out-
patient clinic, rather than being community-based.
Consequently, we have included people who once
sought medical help and who therefore are more
likely to express complaints simply because they
had visited an outpatient clinic. Nonetheless, our
study cohort represents a typical outpatient pop-
ulation that was being investigated for reasons that
frequently lead to the discovery of WML among
healthy, independent living elderly. We intention-
ally included subjects with incidental WML as ad-
vising these subjects reflect everyday clinical prac-
tice. This advice has been limited by the fact that
most studies on this topic have a different design.
It is important to realize that most knowledge on
causes and consequences of WML is based on
either population-based studies or patients with
more advanced stages of dementia, and may not
be applicable to patients with incidental WML.
These studies have improved our understanding
on the etiology and consequences of WML, but
results may not be applicable to individuals who
visit an outpatient clinic. Acquiring more data
on causes and consequences of WML in this particu-
lar group is an important goal of the RUN DMC
study.
Table 3 Mean hippocampal andWML volume (SD) for subjects with and
without subjective cognitive failures (SCF), subjective memory
failures (SMF), and subjective executive failures (SEF)*
Hippocampal volume WML volume No. (%) severeWML
SCF
Present 6.7 (0.9) 14.4 (19.2) 94 (21)
Absent 7.1 (1.1)† 14.6 (12.0) 6 (13)
SMF
Present 6.7 (1.0) 14.4 (19.4) 91 (21)
Absent 7.0 (1.0)† 14.3 (11.6) 9 (16)
SEF
Present 6.7 (0.9) 15.1 (19.8) 71 (24)
Absent 6.9 (1.0) 13.4 (16.5) 29 (15)‡
*Table represents mL, adjusted for age, sex, education, depressive symptoms, intracranial
volume, WML volume, and hippocampal volume where appropriate.
†p 0.02.
‡p 0.05.
WMLwhite matter lesions.
Figure 1 Mean hippocampal volume for
subjects without, with moderate,
and with severe subjective
cognitive failures (SCF), in strata of
objective cognitive performance
(tertiles of compound score for
cognitive function) adjusted for
age, sex, education, depressive
symptoms, intracranial volume,
and white matter lesion volume
Subjects who reported no SCF (good n 26; moderate n
11; poor n10); subjects withmoderate SCF (good n90;
moderate n  100; poor n  91); subjects with severe SCF
(good n 40; moderate n 44; poor n 54).
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A third explanation for the difference in SCF re-
porting is that the high percentage of SCF may be
related to the relatively high proportion of subjects
reporting depressive symptoms (33%) in our cohort
compared to percentages reported in a systematic re-
view (0.4–35%),37 and we were able to adjust for
that.
The strength of this study includes the fact that it
is a large, single center study with a high response; its
structured and extensive assessment of cognitive
functioning performed by only two investigators; the
use of a single MR scanner; the use of a reliable and
sensitive volumetric assessment of WML instead of a
visual rating scale13; the use of a single expert who
segmented the hippocampus with high inter-rater
agreement, blinded to all clinical and radiologic data;
and the opportunity of extensive adjustment for pos-
sible confounders.
Our results are in agreement with two recent
studies, which reported reduced hippocampal vol-
umes in subjects with memory complaints as com-
pared to controls.12,14,15 The unique aspect of our
study was the inclusion of depressive symptoms and
WML volume as covariates, since they are related to
SCF,2,4,25 and to hippocampal atrophy.38
Importantly, the relation between lower hip-
pocampal volume and SCF and SMF was demon-
strated in subjects with good objective performance.
This may provide an underlying pathoanatomic ex-
planation for the frequently observed SCF and may
therefore function as an early marker for the de-
velopment of diseases characterized by memory loss,
including AD and its attendant neuropathologic
substrates such as hippocampal atrophy.4,14,15 Since
memory impairment is mainly related to hippo-
campal neurodegeneration,6,39 it is conceivable that
SCF and SMF are also primarily related to hip-
pocampal atrophy rather than WML. As lower
hippocampal volume is associated with future con-
version to AD,40 SCF can serve as an early predictor
of AD, even in the absence of objective cognitive
impairment.
In our study, SCF and SMF were not related to
WML volume. This in accordance with another
study,3 whereas other studies did report an associa-
tion between WML and cognitive complaints.4,12,25
However, some methodologic considerations of
these studies should be discussed. Most importantly,
they did not adjust for hippocampal volume, which
obviously appears to be related to SCF and SMF. In
addition, the first study25 had a relatively small sam-
ple (n  60) and in the other study4 the severity of
WML was scored semiquantitatively, potentially
leading to an underestimation of the actual WML
burden. This effect may especially be present among
those with severe WML, because of ceiling effects in
semiquantitative rating scales. Yet, in our study se-
vere WML were more frequently observed in subjects
reporting SEF than those who did not. This is in line
with previous studies that found WML to be primar-
ily related to executive functions and speed/motor
control domains.7,36
We found no relation between hippocampal atro-
phy and SCF or SMF in subjects with moderate or
poor objective cognitive performance; this may be
due to a type II error. A previous study found a sim-
ilar association for WML in relation to reported pro-
gression of SCF.4 It has been suggested that the
relation between SCF and objective performance
may be disproportional in subjects with poor cogni-
tive performance, simply because of their cognitive
impairment and inability to judge their own cogni-
tive function.
Subjective cognitive failures may already have a
radiologic fingerprint with an underlying pathoana-
tomic explanation. Future studies should identify
whether progression of failures coincides with these
radiologic observations and whether this parallels ob-
jective cognitive decline.
Received April 22, 2008. Accepted in final form July 1, 2008.
Figure 2 Mean hippocampal volume for
subjects without, with moderate,
and with severe subjective memory
failures (SMF), in strata of
objective memory performance
(tertiles of compound score for
memory function) adjusted for age,
sex, education, depression,
intracranial volume, andWML
volume
Subjects who reported no SMF (good n  28; moder-
ate n  15; poor n  15); subjects with moderate SMF
(good n  97; moderate n  95; poor n  94); subjects
with severe SMF (good n  39; moderate n  52; poor
n  54).
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